40 results
6-K
EX-99.1
SCNI
Scinai Immunotherapeutics Ltd
22 Nov 21
Report of Foreign Private Issuer
6:05am
of control terms, equity-based compensation, retirement and termination of employment benefits and other benefits. The cash bonuses that may be granted under … the following:
Base salary;
Benefits;
Cash bonuses;
Equity based compensation;
Change of control terms; and
Retirement and termination terms
6-K
EX-99.1
SCNI
Scinai Immunotherapeutics Ltd
18 Aug 16
Notice of Annual General Meeting of Shareholders
12:00am
, retirement, disability or due cause, all unvested options allocated shall automatically expire and all vested options allocated will automatically expire … liability protections and reduction of personal risk
B-7
4.6 Vehicle, telephone and reimbursement of expenses
B-8
4.7 Advance notice and retirement grant
6-K
EX-99.1
SCNI
Scinai Immunotherapeutics Ltd
23 Apr 19
Notice of an Extraordinary General Meeting of Shareholders
6:18am
and retirement grant
A-8
Comparative Information
A-11
5.1 External comparison between the company and other companies
A-11
5.2 Internal comparison (within … and indemnification documents, inclusion in the insurance policy and retirement grants.
The remuneration policy was outlined according to the present needs
F-1
EX-10.11
qob6i0 rce79
29 Dec 14
Registration statement (foreign)
12:00am
CORRESP
rx0ikcr2 ns6dd
29 Dec 14
Correspondence with SEC
12:00am
6-K
EX-99.1
krm60mwkxl152
12 Jul 23
Report of Foreign Private Issuer
12:00am
F-1
EX-10.13
ed43791 185l
29 Dec 14
Registration statement (foreign)
12:00am
6-K
EX-99.1
25mfbu3g0n8n
4 Mar 21
Report of Foreign Private Issuer
1:01pm
F-1
ld7mb5
29 Sep 22
Registration statement (foreign)
9:22am
20-F
xkp594z
27 Apr 16
Annual report (foreign)
12:00am
424B4
gcgf5
20 Dec 22
Prospectus supplement with pricing info
11:59am
F-1/A
tumy6wyl48knh
12 Dec 22
Registration statement (foreign) (amended)
5:25pm